Understanding and Responsiveness Level about Cervical Cancer and its Avoidance among Young Women of Pakistan

  • Khan, Ghulam Jilany (Pharmacology and Therapeutics, University of Central Punjab, and Community Pharmacy Section, New Mehmood Pharmacy) ;
  • Naeem, Hafiza Sadaf (Pharmacoeconomics Section, New Mehmood Pharmacy Lahore) ;
  • Khan, Sara (University College of Pharmacy, University of the Punjab) ;
  • Jamshaid, Talha (University of Lyon) ;
  • Sajid, Muhammad Imran (Faculty of Pharmacy (FOP), University of Central Punjab, and Community Pharmacy Section, New Mehmood Pharmacy) ;
  • Bashir, Irfan (Faculty of Pharmacy (FOP), University of Central Punjab, and Community Pharmacy Section, New Mehmood Pharmacy) ;
  • Jamshaid, Muhammad (Faculty of Pharmacy (FOP), University of Central Punjab, and Community Pharmacy Section, New Mehmood Pharmacy)
  • Published : 2014.06.30


Cervical cancer is one of the leading causes of morbidity and mortality amongst the gynecological cancers worldwide, especially in developing countries. There are few to no initial symptoms and signs. This study was conducted to assess the awareness level of young Pakistani women about cervical cancer and to educate them about this deadly disease. A detailed questionnaire regarding demographic data and information about cervical cancer was distributed in different cities of Punjab. A total of 873 women took part in this survey and 70.1 percent were totally unaware of this cancer. Only 8.5% of the whole surveyed population knew accurately about cancer of cervix, 7% of the surveyed respondents correctly specified the human papilloma virus as the causative agent. Only 5.2% respondents were able to identify the Pap smear test as a diagnostic measure. Out of all the surveyed population only 4.3% of individuals were found to be vaccinated against this disease and the majority was found from the medical profession. Medical professionals, students, working women, housewives and uneducated individuals took active part in this survey. This study demonstrates a low level of awareness among Pakistani women and a need for an active campaign by media and government to increase understanding as well as introducing measures for improved prevention and treatment of cervical cancer.


  1. Tas F, Isler A, Esenay FI, Aksit S, Basbakkal Z (2010). Awareness of Turkish nursing students about risk factors for cervical cancer and prophylactic human papillomavirus vaccine. Sex Disabil, 28, 245-53.
  2. Zhao FH, Tiggelaar SM, Hu SY, et al (2012). A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78.
  3. Petignat P, Roy M (2007). Diagnosis and management of cervical cancer. BMJ: Br Med J, 335, 765.
  4. Pitts M, Clarke T (2002). Human papillomavirus infections and risks of cervical cancer: what do women know? Health Education Research, 17, 706-14.
  5. Raychaudhuri S, Mandal S (2012). Current status of knowledge, attitude and practice (KAP) and screening for cervical cancer in countries at different levels of development. Asian Pac J Cancer Prev, 13, 4221-7.
  6. Sankaranarayanan R, Nene BM, Shastri SS, et al (2009). HPV screening for cervical cancer in rural India. N Engl J Med, 360, 1385-94.
  7. Schoueri-Mychasiw N, McDonald PW (2013). Factors Associated with Underscreening for Cervical Cancer among Women in Canada. Asian Pac J Cancer Prev, 14, 6445-50.
  8. Turkistanli EC, Sogukpinar N, Saydam B K, Aydemir G (2003). Cervical cancer prevention and early detection; the role of nurse and midwives. Asian Pac J Cancer Prev, 4, 39-44.
  9. Villa LL, Costa RLR, Petta CA, et al (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer, 95, 1459-66.
  10. Wheeler CM (2007). Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nature Clinical Practice Oncology, 4, 224-35.
  11. Kumar V, Abbas AK, Fausto N, Mitchell RN (2007). Robbins Basic Pathology (8th ed.) Saunders Elsevier. pp. 718-21.
  12. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al (2005). Costeffectiveness of cervical-cancer screening in five developing countries. N Engl J Med, 353, 2158-68.
  13. Hong Y, Zhang C, Li X, Lin D, Liu Y (2013). HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. BMC Public Health, 13, 696.
  14. Khan S, Jaffer NN, Khan M N, et al (2007). Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis, 11, 313-7.
  15. Lee PW, Kwan TT, Tam KF, et al (2007). Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med, 45, 130-4.
  16. Lowy DR, Schiller JT (2006). “Prophylactic human papillomavirus vaccines”. J Clin Invest, 116, 1167-73.
  17. Moore MA, Ariyaratne Y, Badar F, et al (2010). Cancer epidemiology in South Asia-past, present and future. Asian Pac J Cancer Prev, 11, 49-66.
  18. Moosa NY, Khattak N, Alam MI, et al (2014). Comparison of Cervical Cell Morphology Using Two Different Cytology Techniques for Early Detection of Pre-Cancerous Lesions. Asian Pac J Cancer Prev, 15, 975-81.
  19. Munoz N, Bosch FX, Castellsague X, et al (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 111, 278-85.
  20. Ozkahraman S, Yildirim B (2012). Knowledge levels of Turkish nurses related to prevention and early diagnosis of cancer. Asian Pac J Cancer Prev, 13, 6105-8.
  21. Chen Q, Luo ZY, Lin M, et al (2012). Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province. Asian Pac J Cancer Prev, 13, 1519-24.
  22. Berraho M, Bendahhou K, Obtel M, et al (2012). Cervical cancer in Morocco: epidemiological profile from two main oncological centers. Asian Pac J Cancer Prev, 13, 3153-7.
  23. Canavan TP, Doshi NR (2000). Cervical cancer. American family physician, 61, 1369-76.
  24. Cerigo H, Macdonald ME, Franco EL, Brassard P (2012). Inuit women's attitudes and experiences towards cervical cancer and prevention strategies in Nunavik, Quebec. Int J Circumpolar Health, 71.
  25. Demirtas B, Acikgoz I (2013). Promoting attendance at cervical cancer screening: understanding the relationship with Turkish womens' health beliefs. Asian Pac J Cancer Prev, 14, 333-40.
  26. Farhath S, Vijaya PP, Mumtaj P (2013). Cervical cancer: is vaccination necessary in India? Asian Pac J Cancer Prev, 14, 2681-4.
  27. Ferlay J (2001). GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC press.
  28. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
  29. Ghojazadeh M, Azar ZF, Saleh P, Naghavi-Behzad M, Azar NG (2012). Knowledge and attitude of Iranian university students toward human papilloma virus. Asian Pac J Cancer Prev, 13, 6115-9.
  30. Giles M, Garland S (2006). A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol, 46, 311-5.
  31. Akinyemiju TF (2012). Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PloS One, 7, 48834.
  32. Ali SF, Ayub S, Manzoor NF, et al (2010). Knowledge and awareness about cervical cancer and its prevention amongst interns and nursing staff in Tertiary Care Hospitals in Karachi, Pakistan. PLoS One, 5, 11059.

Cited by

  1. Challenges of Providing Cervical Cancer Prevention Programs In Iran: A Qualitative Study vol.15, pp.23, 2015,
  2. A review of knowledge and attitudes of young people on cervical cancer and HPV vaccination pp.1613-2238, 2019,